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Structure–function relationships in proteins are predicated on the
spatial proximity of noncovalently interacting groups of atoms. Thus,
structural elements located away from a protein’s active site are
typically presumed to serve a stabilizing or scaffolding role for the
larger structure. Here we report a functional role for a distal structural
element in a PDZ domain, even though it is not required to maintain
PDZ structure. The third PDZ domain from PSD-95/SAP90 (PDZ3) has
an unusual additional third alpha helix (3) that packs in contiguous
fashion against the globular domain. Although 3 lies outside the
active site and does not make direct contact with C-terminal peptide
ligand, removal of 3 reduces ligand affinity by 21-fold. Further
investigation revealed that the difference in binding free energies
between the full-length and truncated constructs is predominantly
entropic in nature and that without 3, picosecond-nanosecond
side-chain dynamics are enhanced throughout the domain, as deter-
mined by 2H methyl NMR relaxation. Thus, the distal modulation of
binding function appears to occur via a delocalized conformational
entropy mechanism. Without removal of 3 and characterization of
side-chain dynamics, this dynamic allostery would have gone unno-
ticed. Moreover, what appeared at first to be an artificial modification
of PDZ3 has been corroborated by experimentally verified phosphor-
ylation of 3, revealing a tangible biological mechanism for this novel
regulatory scheme. This hidden dynamic allostery raises the possibil-
ity of as-yet unidentified or untapped allosteric regulation in this PDZ
domain and is a very clear example of function arising from dynamics
rather than from structure.
NMR  PSD-95  spin relaxation  entropy
Proteins owe their functionality to the 3-dimensional arrange-ment of atoms. A typical protein’s structure stabilizes its
active site, allowing for specific interactions with substrate or
ligand. These basic structure–function relationships are well
understood for countless types of proteins. Because most active
sites are relatively small, it has been presumed that the remaining
bulk of the globular structure provides a scaffolding role. Thus,
even though similar domains belonging to the same family may
have substrate specificity preferences, the folds of those domains
are composed of invariant structural elements (1). Nonetheless,
variations in tertiary fold composition, such as additional ele-
ments of secondary structure, are not uncommon. An example
of this can be seen within the PDZ domain family of proteins.
From this, the question of whether there is a specific role for such
auxiliary structural elements remains open. In other words, how
might these additional elements influence the core domain?
PDZ domains (eg, PSD-95, Discs Large, Zo-1) are small, 90-aa
modular structures that typically bind C-terminal tails (4–6
residues) of target proteins (2). They are frequently found in
multiple copies in proteins with diverse functions, especially those
involved in signal transduction complexes and in the anchoring of
receptors at membrane specializations (2–4). Thus, one common
function of PDZ domains is to provide scaffolding. Although the
PDZ family has a highly conserved fold consisting of a 5- or
6-stranded half -barrel and 2 -helices (5), some members exhibit
additional secondary structural elements or differences in lengths
of helices, -strands, or loops (6–9). For instance, the third PDZ
domain from the PSD-95/SAP90 protein (referred to herein as
PDZ3) contains an additional -helix at its carboxyl terminus (3)
that was first reported in its homologue Dlg1 (5, 6). It is ironic that
this atypical helix is present in PDZ3, because PDZ3 is considered
the archetype of PDZ domains, being the first PDZ domain
structure to be solved (2). Naively, 3 is not expected to impact
function, because it lies on a different surface from the PDZ
ligand-binding site (Fig. 1). However, studies on various proteins
have shown that intramolecular communication can occur between
sites that would not be expected to be energetically linked based on
protein structure alone (10–14). This notion was exemplified early
on in the PDZ domain family using coevolutionary analysis, from
which an evolutionarily conserved communication pathway was
proposed (15). Subsequently, individual PDZ domains were found
to exhibit allosteric behavior (8, 16–19). For these reasons, we
investigated the role of 3 in PDZ3 function, structure, and
dynamics.
Here we show that the 3 appendage to PDZ3 modulates
C-terminal peptide binding function through a novel, dynamics-
based mechanism. Removal of 3 has a minimal effect on global
PDZ3 structure, but results in a 21-fold reduction in binding
affinity that is entirely entropic in origin, within experimental error.
Backbone (15N) and side-chain (2H methyl) NMR relaxation ex-
periments indicate that removal of 3 results in increased side-chain
dynamics throughout the structure on time scales faster than 6 ns.
These enhanced motions are quenched on peptide binding, pro-
viding the entropic driving force for the reduced binding affinity.
This example of dynamically regulated binding combines features of
dynamic allostery observed at the backbone level (20) with the
control of ligand-binding affinity through the tuning of side-chain
conformational entropy (21). These findings, along with the recent
report that Tyr-397 in 3 is phosphorylated (22), provide support
for the intriguing possibility that in vivo, PDZ3 function may be
regulated by an entropically controlled dynamic mechanism. That
this particular PDZ domain is not known to be allosteric or to
undergo conformational change (5, 23) suggests that similar mech-
anisms might be found in other PDZ domains, such as PDZ from
harmonin (24), or even in a wide variety of domain types.
Results
The third PDZ domain of the neuronal signaling protein PSD-
95/SAP90 (PDZ3, residues 303–402) contains an uncharacter-
istic, third -helix (3, residues 394–399) at its C-terminus that
packs up against the core domain (the widely conserved 5 or 6
-strands and 2 -helices) in a region distinct from the peptide
ligand-binding pocket (Fig. 1) (5). The closest end-to-end ap-
proach between 3 and peptide is made at the 3 position (Gln)
of peptide [using the numbering scheme of Doyle et al. (5)],
whose side-chain nitrogen is located 6 Å from the hydroxyl
oxygen of Tyr-397 (Fig. 1). There are no bridging waters, and the
remaining residues of 3 and peptide ligand extend away from
each other; all C–C distances are 10 Å. Thus, 3 does not
directly contact the peptide. To investigate the role of 3 in
PDZ3 function and behavior, a C-terminal truncation mutant
(7ct) was constructed with residues 396–402 removed. This
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truncation was engineered to disrupt the helix while leaving the
core PDZ domain intact.
Consistent with previous studies (25), 7ct retains its native PDZ
structure. The 1H-15N heteronuclear single quantum coherence
(HSQC) spectrum shows a well-dispersed single set of peaks,
indicative of a well-folded protein (Fig. 2). Aside from 3, all
secondary structures are intact, as determined from 13C chemical
shifts (26). A more detailed analysis of potential structural effects
is provided below. These data show that 7ct is stable with a typical
PDZ fold. Having verified no gross structural changes in 7ct, we
set out to study the thermodynamics, structure, and dynamics of this
system and found that 3 has a significant effect on both ligand-
binding affinity and the internal dynamics of PDZ3.
Binding Thermodynamics of 7ct-PDZ3. Isothermal titration calorim-
etry (ITC) was used to evaluate the thermodynamic characteristics
of 7ct and the full-length PDZ3 (i.e., PDZ3303–402) binding to a
peptide derived from the carboxyl terminus of CRIPT (Ac-
TKNYKQTSV-COOH), a naturally occurring binding partner for
PDZ3 (27). For PDZ3303–402, binding occurs with relatively high
affinity (Kd  1.2  0.1 M), whereas truncation lowers the affinity
(Kd  25.7  3.6 M), as shown in Fig. 3 and summarized in Table
1. This demonstrates an important role for 3 in PDZ3’s binding
function. Interestingly, the enthalpic contribution to the free energy
of binding is nearly identical for both constructs, whereas -TS
changes from 1.7 kcal/mol for PDZ3303–402 to 4.0 kcal/mol for 7ct
at 25 °C (Table 1). Thus, the difference in binding is entropic in
origin. Because binding takes place in a separate location from 3,
and there is no change in the enthalpic contribution to binding
between the 2 constructs (which might reflect structural changes),
differences in desolvation on binding are an unlikely source of the
entropic change. It is possible that the core PDZ domain undergoes
some structural adjustment such that individual changes in enthalpy
cancel out, resulting in differences in desolvation on binding. There
is no direct evidence of this, however. The remaining possible
entropy-based explanation for the reduced affinity of 7ct for
peptide is that significant changes in the conformational entropy of
the system occur after removal of 3.
3 Modulates Picosecond-Nanosecond Dynamics Throughout PDZ3.
To investigate the source of any differences in conformational
entropy on binding, we used backbone (28) and side-chain (29)
NMR spin relaxation experiments to monitor the picosecond-
nanosecond (ps-ns) dynamics of both the free and bound forms of
PDZ3303–402 and 7ct. For the backbone, 15N T1, T2, and {1H}-15N
NOE relaxation experiments were acquired at 2 field strengths (500
and 600 MHz) to achieve high-quality fits of the spectral density
function. The relaxation analysis used statistical model selection to
yield rigorous model-free order parameters for N-H bond vectors,
S2. The order parameter is a measure of a given bond’s angular
rigidity (on a scale of 0–1) on timescales faster than the overall
rotational tumbling time (30), which in this case is on the order of
6 ns. For side-chain groups, methyl 2H relaxation data sets (IzCz,
IzCzDz, and IzCzDy) at 2 field strengths (500 and 600 MHz) were
fitted to obtain the order parameter corresponding to the methyl
C–CH3 bond, denoted by S2axis (31).
Order parameters were first compared between PDZ3303–402 and
7ct constructs in the absence of CRIPT peptide. Backbone N-H
bond vectors showed limited changes in S2 after removal of 3 (Fig.
4A). The largest observed changes were increased flexibility for a
Fig. 1. Structure of PSD-95/SAP90 PDZ3 complexed with CRIPT peptide. The 3
helix is shown in blue. The van der Waals surface of the CRIPT peptide is in purple,
and the nearest approaching residues (Tyr-397 and Phe-400) of 3 are in cyan.
Fig. 2. 1H-15N HSQC spectrum of PDZ3303–402 (black) overlain with the 1H-15N
HSQC spectrum of 7ct (red). Resonances with 1H-15N assignments for deleted
residues 396–402 are indicated by arrows.
Fig. 3. The 3 helix affects CRIPT peptide binding. ITC data for binding of
PSD-95/SAP90 PDZ3303–402 (A) and 7ct (B) to C-terminal 9 residues of CRIPT
(Ac-TKNYKQTSV-COOH) at 25 °C. Thermograms and integrated titration
curves are shown in the top and bottom panels, respectively. Heats of dilution
were obtained from independent buffer–buffer titration experiments (see
Materials and Methods).
Table 1. Thermodynamic parameters for the PDZ3–CRIPT peptide
interaction at 25 °C
Protein Kd (M) H (kcal/mol) TS (kcal/mol)
PDZ3303–402 1.2 (0.1) 9.70 (0.12) 1.66 (0.06)
7ct 25.7 (3.6) 10.27 (0.68) 4.00 (0.59)
Values are the average of 2 independent experiments. The fitted stoichi-
ometry (n) ranged from 0.95 to 1.06.
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limited number of residues in the range of 0.1–0.4. Specifically, S2
values were 0.15 for residues Glu-334 and Gly-335 in the loop
between 2 and 3, and 0.4 and 0.1, respectively, for residues
Asp-357 and Ile-359 in 4. The changes also may reflect differences
in the number of model-free parameters used (e.g., for 357,
introduction of S2s in 7ct), which is a caveat of model selection. It
also should be noted that no significant Rex contributions (2 Hz)
were found in either of the 2 constructs. In addition, the carboxyl
terminus of 7ct lacks an 3 structure and thus exhibited a large
increase in flexibility relative to PDZ3303–402. Otherwise, most of
the backbone dynamics remained largely unaffected by the trun-
cation, consistent with retention of global PDZ structure. In
contrast, side-chain methyl groups showed significantly increased
flexibility at most of the observed sites. Decreased S2axis values
appear throughout the domain, with an average S2axis (7ct 
PDZ3303–402) of 0.12 and no apparent pattern (Fig. 4B).
In principle, a uniform decrease in S2axis values could be due to
inaccurate determination of the global tumbling correlation time,
m, of either 7ct or PDZ3303–402. Several lines of evidence strongly
argue that this is not the case here. First, an inaccurate m would
lead to a uniform offset in backbone order parameters, which was
not observed (Fig. 4A). Second, simulations showed that a relatively
large error in m (1 ns) would be needed to account for the
majority of the observed decreases in S2axis. Global m times of 5.9
ns and 6.0 ns were calculated for the PDZ3303–402 and 7ct
constructs, respectively, which are characteristic of a globular
protein of 10 kDa (see Materials and Methods for all m values).
Third, both 15N and 2H relaxation on independent protein prepa-
rations of 7ct were performed, and measurements also were made
on fresh 7ct samples of reduced concentration (0.3–0.4 mM).
These data consistently yielded the same overall result, indicating
increased side-chain flexibility in 7ct (data not shown). Finally,
binding CRIPT peptide to 7ct resulted in S2axis values that were
almost indistinguishable from the corresponding PDZ3303–402 com-
plex (see below). Thus, we conclude that the determined values of
m are accurate, and that the presence of 3 has a profound effect
on the side-chain dynamics throughout the protein.
The ps-ns dynamics of 7ct and PDZ3303–402 when bound to
CRIPT peptide were also determined, completing the dynamics
characterization of a cycle composed of peptide binding and
presence or absence of 3 (Fig. 5). At the backbone level, overall
changes in S2 were negligible; the largest average S2 change between
any 2 forms was 0.02. At the side-chain level, as mentioned above,
the average S2axis (7ctfree  PDZ3303–402free) was found to be
0.12, indicating significant change in S2axis. The average S2axis
for the remaining sides of the cycle were determined to be
0.00 (7ctbound  PDZ3303–402bound), 0.00 (PDZ3303–402bound 
PDZ3303–402free), and 0.12 (7ctbound  7ctfree). Unlike the back-
bone, many individual side-chain order parameters in both PDZ
constructs are sensitive to peptide binding, similar to previous
observations in another PDZ domain (16). It is worth reiterating
that binding of peptide to 7ct caused extensive side-chain rigidi-
fication, such that the S2axis values of the complex were nearly
indistinguishable from the PDZ3303–402 complex (Fig. 5), with a
Pearson correlation coefficient of 0.98. In simple terms, binding
peptide to 7ct ‘‘snaps’’ the side-chain dynamics back to that of
CRIPT-bound PDZ3303–402.
In summary, removal of the 3 structural element in PDZ3
results in a significant global reduction in S2axis, indicating a global
increase in side-chain flexibility for the truncation mutant, 7ct,
relative to PDZ3303–402. Binding peptide then returns the side-chain
dynamics profile to that nearly identical with PDZ3303–402. This
global quenching of motions represents a substantial loss of con-
formational entropy and corroborates the calorimetrically observed
entropic changes on binding.
Long-Range Modulation of Ligand Binding. Although 3-mediated
enhanced peptide binding is entropy-driven, part of the binding
affinity could be due to weak or transient interactions between 3
and the CRIPT peptide that are not visible in the crystal structure
(5, 6). In that complex, no electron density was observed for the side
chain of lysine at the 4 position or for any of the 4 preceding
residues. To assess whether binding interactions might occur at
other positions in the peptide, chemical shifts of the CRIPT peptide
were monitored as a function of PDZ3 concentration from natural
abundance 1H-13C HSQC spectra. The chemical shifts were as-
signed for free, unstructured peptide, and resonances were tracked
in the presence of 7.5% and 15% molar ratios of PDZ3303–402 to
peptide. Normalized chemical shift changes () were observed at
positions 0 to 3, but no shift perturbations occurred at other, more
N-terminal positions in the peptide (Fig. 6). This confirms that only
the 4 C-terminal residues of the peptide ligand makes significant
contact with PDZ3303–402. More importantly, it rules out transient
contacts between the Tyr at position 6 and elements of 3 that
might explain how removal of 3 lowers binding affinity. We thus
conclude that 3 is unequivocally distal to the CRIPT peptide-
binding site and that 3 must confer binding energy through an
indirect, allosteric mechanism.
Chemical shift perturbation analysis was used to assess how 3
affects PDZ structure as a function of peptide binding. Amide
15N/1H chemical shift changes () in PDZ3303–402 and 7ct in
response to saturating amounts of CRIPT peptide were compared.
Comparative shift perturbations due to peptide binding—rather
than the raw effect of 3 removal—were used, because numerous
shift perturbations in the PDZ core (Fig. 2) result from removal of
the many interactions that 3 imparts, even without structural
changes. Indeed, there are 4 aromatic side chains at this interface,
2 of which are on 3 (Tyr-397 and Phe-400). Removal of 3 thus
leads to large changes in ring current shift effects in the PDZ core
and in loop residues neighboring those aromatic groups. In contrast,
comparative shift perturbations (in response to binding) subtracts
out these 3 interface effects. Shift perturbations brought about by
peptide binding in PDZ3303–402 are closely mirrored in 7ct (Fig. 7).
This indicates that 3 does not affect the structural response to
peptide binding, which has been shown to be negligible for
PDZ3303–402 (5). Therefore, a structure-based mechanism for the
long-range modulation of peptide-binding affinity is subtle at best
and unlikely to be at work here, underscoring the importance of
dynamics in this system.
Fig. 4. 3 helix-dependent changes in backbone and side-chain order
parameters. (A) Backbone HN groups (S2) as determined from 15N relaxation.
(B) Side-chain methyl groups (S2axis) as determined from 2H relaxation. S2axis
values for PDZ3303–402 were previously reported by Law et al. (44).

























Here we report on a noncanonical structural appendage that
regulates the internal dynamics and function of a common,
conserved domain. Removal of the C-terminal third helix (3)
from the third PDZ domain (PDZ3303–402) of PSD-95/SAP90
causes a global increase in ps-ns side-chain flexibility, which
becomes quenched on the binding of C-terminal peptide ligand.
This quenching incurs a conformational entropy penalty that is
consistent with an overall reduction in CRIPT peptide affinity
for the truncated construct (7ct) relative to the longer
PDZ3303–402. Isothermal titration calorimetry confirmed that
this reduction is entirely entropic in nature, within experimental
error (Table 1). Because 3 is seated outside the ligand-binding
pocket, differences in solvation do not easily explain this entropic
effect. Therefore, given the direct observation of modulation in
side-chain dynamics as detected by 2H relaxation, the affinity
reduction is explained by side-chain entropy, rather than by a
structure-based mechanism. Thus, due to the (i) lack of signif-
Fig. 5. Methyl side-chain dynamics of PDZ3303–402 as a function of removal of 3 (left to right) and CRIPT peptide binding (top to bottom). C atoms of the
corresponding methyl-bearing residues are color-coded according to S2axis parameters: yellow, 0  S2axis  0.4; orange, 0.4  S2axis  0.7; red, 0.7  S2axis  1. Average
S2axis values for each state are indicated by green bars.
Fig. 6. Chemical shift perturbations in CRIPT 7-mer peptide (Ac-NYKQTSV-
COOH) on addition of 7.5% and 15% molar ratios of PDZ3303–402 to peptide. Shift
perturbations were observed from natural abundance 1H-13C HSQC spectra. The
asterisk denotes a lack of chemical shift data due to line broadening.  is a
weighted vector combination of 1H and 13C chemical shift perturbations, as
described in Materials and Methods.
Fig. 7. Chemical shift perturbations of PDZ3 on peptide binding. (A) Combined
1H and 15N perturbations (defined in text) are shown for PDZ3303–402 and 7ct
constructs. Residues that make up the binding pocket are shaded in blue. (B)
Chemical shift perturbations from (A) mapped onto the structure. Residues are
color coded as follows: yellow, 0 ppm    0.2 ppm; orange, 0.2 ppm   
0.5 ppm; red, 0.5 ppm  .
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icant structural changes, (ii) lack of direct interactions between
3 and CRIPT peptide residues, and (iii) participation of ps-ns
side-chain dynamics throughout the domain, this 3/PDZ3/
peptide ligand system is a clear example of allostery mediated by
fast side-chain dynamics. It is allosteric in that 3 and the ligand
are distal to one another, and it is also allosteric in the sense that
it is driven by dynamic changes outside the ligand-binding site.
We also note that several backbone sites, such as residues
Glu-334 and Gly-335 in the glycine-rich 2-3 loop, appear to
behave like the side chains and contribute to the overall effect.
Importantly, because this is observed in a small protein domain
not prone to structural changes and considered ‘‘rigid’’ (23), it
suggests that any folded protein could in principle use dynamic
allostery as a regulatory mechanism, although recognition of this
mechanism likely would require characterization of side-chain
dynamics.
The finding that the distal 3 element can regulate PDZ3
function raises an interesting question as to whether this dynamic
allostery has a defined biological role. In support of this, PSD-95 has
been shown to be phosphorylated at multiple positions (32, 33),
including Tyr-397 (22) located in the 3 helix. Because the Tyr
phenol ring packs against the core PDZ domain, phosphorylation
would alter 3 packing or lead to loss of 3 structure, either of
which could affect ligand affinity. Although Tyr-397 is partially
buried in the crystal structure, its accessibility to kinases should be
significant, based on the high amide exchange rates within 3 (25)
(data not shown for PDZ3303–402). A particularly relevant finding
comes from the Drosophila homologue Discs Large (Dlg) protein,
which, along with PSD-95, belongs to the MAGUK (membrane-
associated guanylate kinase) family of proteins (34). It was shown
that deletion of a portion of 3 (residues corresponding to PSD-95
396–401) disrupts the interdomain communication between PDZ3
and the SH3-GK module located 25 residues downstream; in turn,
this communication was shown to modulate Dlg binding to the
localization protein GukHolder (35). This suggests that the highly
conserved linker region between PDZ3 and the SH3 domains is
essential for modulating both intramolecular and intermolecular
interactions (35). Furthermore, it seems reasonable that the phos-
phorylation state and conformation of 3 could play an important
role in this regulation. Thus, in a broader context, the dynamic
allostery observed here with PDZ3 arises out of a larger, more
complex interdomain regulatory scheme. Such regulatory mod-
ules within the context of larger interdomain interactions have
previously been reported in the case of the GTPase exchange
factor Vav1 (36).
Dynamics-based modulation of binding affinity has previously
been reported in 2 notable cases. First, negative cooperative binding
of cAMP to the dimeric catabolite activator protein was found to
be driven by ps-ns backbone dynamics (20). Specifically, binding of
the first cAMP occurs with little change in backbone flexibility,
whereas binding the second cAMP triggers rigidification through-
out both subunits and thus has a substantial conformational en-
tropic cost (20). In the second example, changes in side-chain
conformational entropy in calmodulin were shown to correlate
remarkably well with calorimetric entropy changes for a series of
calmodulin-binding peptides binding to calmodulin (21). In relation
to these studies, the critical difference in the present study is that the
long-range dynamic mechanism becomes apparent only after re-
moval of the 3 helix. Furthermore, the driving force occurs
through side-chain equilibrium dynamics, rather than effects from
the backbone. In this sense, the data presented here bridge the
side-chain entropy findings of Frederick et al. (21) with the dynam-
ically driven allosteric effect reported by Popovych et al. (20). Our
results provide further support for the general notion of entropy
vis-à-vis dynamics as a bona fide mechanism for allosteric commu-
nication without conformational change (10, 37–39).
Materials and Methods
Cloning, Expression, and Purification of PSD-95/SAP90 PDZ3. The third PDZ
domain of PSD-95/SAP90 from Rattus norvegicus was subcloned into a T7 expres-
sion vector (pET28a; Novagen) using primers designed to amplify residues 303–
402 [using the numbering scheme of Doyle et al. (5)] of the full-length plasmid of
PSD95/SAP90 (a gift from Ken Prehoda). The PSD-95 PDZ3 plasmid was trans-
formed into DE3 Star Eschericha coli cells and grown in minimal media supple-
mented with the appropriate isotope for the desired labeling scheme, as de-
scribed previously (16). A 50-mL starter culture was grown for 18 h and used to
inoculate 950 mL of culture media. Protein expression was induced by adding
isopropyl -D-1-thiogalactopyranoside to a final concentration of 1 mM once the
bacteria reached an OD600 of 0.6–0.8. The culture was allowed to grow for 4 h
at 37 °C. Bacteria were harvested by centrifugation and frozen until further use.
Frozen, pelleted cells were resuspended in lysis buffer [50 mM Tris, 150 mM NaCl,
10 mM EDTA (pH 6.8)] and lysed using 2 freeze–thaw steps followed by ultra-
sonication. The PDZ3303–402 protein was purified using Source-Q (GE Biosciences)
chromatography media, followed by Fast-Flow Q-Sepharose chromatography
(GE Biosciences). Pooled fractions containing PDZ were subjected to size-
exclusion chromatography using a G50-Sephadex column (GE Biosciences) equil-
ibrated in NMR buffer [20 mM NaPO4, 50 mM NaCl, 1 mM EDTA (pH 6.8)]. Typical
yields were 30 mg/L with 95% purity, as verified by SDS/PAGE analysis.
Generation of 7ct. The 7ct truncation mutant (PSD-95/SAP90 numbering
303–395) was generated by PCR using oligonucleotides designed to amplify DNA
within the 3 helix. This amplified DNA was subcloned into a T7 expression vector
(pET28a; Novagen). Purification of truncated PDZ3 (7ct) was achieved in the
same manner as for PDZ3303–402.
Peptide Synthesis. The C-terminal peptide from CRIPT (Ac-TKNYKQTSV-COOH or
Ac-NYKQTSV-COOH) was manually synthesized using standard Fmoc solid-phase
peptide chemistry. Peptide cleavage from the Wang resin and side-chain depro-
tection were achieved simultaneously using TFA:triisopropyl silane:anisole:water
(90:5:3:2) for 2 h under nitrogen. The volume of filtrate was reduced under a
stream of nitrogen, followed by peptide precipitation using 60 mL of cold diethyl
ether. The mixture was extracted 3 times with 0.1% TFA in water (20 mL each).
The aqueous phase was then combined and lyophilized. The crude powder was
dissolved in water and then purified by reverse-phase (C18) HPLC using a linear
gradient from 0 to 20% (95% acetonitrile, 4.9% water, 0.1% TFA) over 10 min,
followed by a gradient from 20% to 35% over 15 min. Pure CRIPT was eluted at
20–22 min. The final peptide product was verified by mass spectrometry.
Isothermal Titration Calorimetry. ITC was carried out on a Microcal VP-ITC
microcalorimeter at 25 °C. All measurements were collected by titration of CRIPT
peptide into the protein solution. Both protein and peptide ITC buffer solutions
were composed of 20 mM NaPO4, 50 mM NaCl, and 1 mM EDTA (pH 6.8). The pH
of the peptide and protein solutions were determined to be identical to within
0.02 pH units at room temperature. All solutions were degassed for 5–10 min
without stirring and kept on ice before the ITC experiments.
For all ITC experiments, PDZ3 (100 M) was placed in the sample chamber (ca.
2 mL), while the peptide solution (1 mM) was transferred into a 250-L injection
syringe. Each titration experiment comprised a single 2-L injection, followed by
7-L injections at 180-s intervals. The c values for PDZ3303–402 and 7ct were 90
and 5, respectively. To account for the heat of dilution, an identical calorimetry
experiment was performed in the absence of protein. The data from each
experiment were collected and analyzed using ORIGIN version 5.0 (Microcal).
Thermodynamic parameters were determined using nonlinear least squares
fitting, assuming a single-site–binding model. The parameters reported are the
results of 2 independent measurements.
NMR Spectroscopy. NMR experiments were carried out at 25 °C (calibrated using
amethanol standard)usingVarian Inovaspectrometersequippedwith 1H/15N/13C
probes and z-axis pulsed-field gradients operating at 500- and 600-MHz 1H
frequencies. For both PDZ3303–402 and 7ct in free and bound forms, backbone
and side-chain methyl groups were assigned using standard triple-resonance
assignment experiments. Stereospecific assignments were obtained from a 10%
13C-labeled PDZ3 sample (40). All NMR experiments were processed using
NMRPipe and analyzed using NMRView compiled for Linux workstations (41,
42). Chemical shift perturbation analysis was performed using a weighted
vector combination of shifts, calculated by applying the formulas [H2 
(0.25*C) 2]0.5 for 1H-13C shifts and [H2  (0.1*N) 2]0.5 for 1H-15N shifts.
15N Backbone Relaxation. 15N T1, T2, and {1H}-15N NOE values were obtained
through standard experiments (28) at 500 and 600 MHz for PDZ3303–402 (1.0
mM) and 7ct (1.0 mM), both bound and free forms. For T1 and T2 experiments,
























9 relaxation time points along with 3 duplicates were typically collected. For the
{1H}-15N NOE, a recycle delay of 4.5 s was used. Relaxation decays were best fit to
single exponentials using in-house programs. For Lipari-Szabo analysis, global m
correlation times were found to be 5.89 ns for PDZ3303–402free, 6.23 ns for
PDZ3303–402bound, 5.98 ns for 7ctfree, and 6.34 ns for 7ctbound. Anisotropic rota-
tional models were tested, but it was concluded that the isotropic rotational
model was the best for both PDZ3303–402 and 7ct (data not shown). To assess
potential aggregation effects on global m, 15N relaxation sets were indepen-
dently collected and analyzed at 2 different concentrations (1.0 and 0.4 mM) for
bothconstructsusing independentlypreparedprotein samples (datanot shown).
For each residue, the selection of 1 of 5 standard model-free models (S2; S2 and e;
S2 and Rex; S2, e, and Rex; or S2s, S2f, and s) were carried out using RVI software,
a front-end interface for relxn2.2 that analyzes 15N relaxation using simple
model-free formalism(30)andtheAkaike informationcriterion (43),asdescribed
previously (14).
2H-Methyl Relaxation. Side-chain 2H-methyl relaxation experiments were col-
lected for samples containing randomly fractionally incorporated 2H (29). Multi-
coherence relaxation experiments (IzCzDz, IzCzDy, and IzCz) were collected at 500
and 600 MHz (29). For each experiment, 9 relaxation time points along with 3
duplicate points were collected for PDZ3303–402 (1.0 mM) and 7ct (1.0 mM) in
both free and bound forms. All decays were best fit to single exponentials.
Side-chain order parameters (S2axis) were derived from fits of S2 and e to the data
using the appropriate isotropic m values determined for each construct.
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